Apriem Advisors Bristol Myers Squibb CO Transaction History

Apriem Advisors

  • $849 Million
  • Q3 2024

A detailed history of Apriem Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Apriem Advisors holds 14,977 shares of BMY stock, worth $863,424. This represents 0.09% of its overall portfolio holdings.

Number of Shares
14,977
Holding current value
$863,424
% of portfolio
0.09%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$39.66 - $51.75 $593,987 - $775,059
14,977 New
14,977 $775,000
Q1 2024

May 15, 2024
SELL
$47.98 - $54.4 $64,533 - $73,168
-1,345 Reduced 23.86%
4,291 $232,000
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $33,160 - $39,569
-684 Reduced 10.82%
5,636 $289,000
Q3 2023

Nov 13, 2023
SELL
$57.89 - $64.73 $3,820 - $4,272
-66 Reduced 1.03%
6,320 $366,000
Q2 2023

Aug 08, 2023
BUY
$63.71 - $70.74 $254 - $282
4 Added 0.06%
6,386 $408,000
Q1 2023

May 12, 2023
BUY
$65.71 - $74.53 $262 - $298
4 Added 0.06%
6,382 $442,000
Q4 2022

Feb 13, 2023
BUY
$68.48 - $81.09 $71,082 - $84,171
1,038 Added 19.44%
6,378 $458,000
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $24 - $14,522
-189 Reduced 3.42%
5,340 $380,000
Q2 2022

Aug 08, 2022
BUY
$72.62 - $79.98 $290 - $319
4 Added 0.07%
5,529 $426,000
Q1 2022

May 10, 2022
BUY
$61.48 - $73.72 $12,418 - $14,891
202 Added 3.79%
5,525 $404,000
Q4 2021

Feb 09, 2022
SELL
$53.63 - $62.52 $34,752 - $40,512
-648 Reduced 10.85%
5,323 $332,000
Q3 2021

Nov 12, 2021
BUY
$59.17 - $69.31 $7,218 - $8,455
122 Added 2.09%
5,971 $353,000
Q2 2021

Aug 10, 2021
SELL
$61.91 - $67.42 $4,271 - $4,651
-69 Reduced 1.17%
5,849 $391,000
Q1 2021

May 10, 2021
SELL
$59.34 - $66.74 $36,494 - $41,045
-615 Reduced 9.41%
5,918 $374,000
Q4 2020

Feb 04, 2021
BUY
$57.74 - $65.43 $53,178 - $60,261
921 Added 16.41%
6,533 $405,000
Q3 2020

Nov 10, 2020
SELL
$57.43 - $63.64 $15,908 - $17,628
-277 Reduced 4.7%
5,612 $338,000
Q2 2020

Aug 07, 2020
BUY
$54.82 - $64.09 $80,530 - $94,148
1,469 Added 33.24%
5,889 $346,000
Q1 2020

May 07, 2020
BUY
$46.4 - $67.43 $23,942 - $34,793
516 Added 13.22%
4,420 $246,000
Q4 2019

Feb 10, 2020
BUY
$49.21 - $64.19 $192,115 - $250,597
3,904 New
3,904 $251,000
Q1 2019

May 15, 2019
SELL
$45.12 - $53.8 $180,615 - $215,361
-4,003 Closed
0 $0
Q4 2018

Feb 19, 2019
SELL
$48.76 - $63.23 $29,256 - $37,938
-600 Reduced 13.03%
4,003 $208,000
Q3 2018

Nov 14, 2018
SELL
$55.19 - $62.25 $10,982 - $12,387
-199 Reduced 4.14%
4,603 $286,000
Q2 2018

Aug 14, 2018
SELL
$50.53 - $62.98 $85,799 - $106,940
-1,698 Reduced 26.12%
4,802 $266,000
Q1 2018

May 11, 2018
SELL
$59.92 - $68.98 $16,418 - $18,900
-274 Reduced 4.04%
6,500 $411,000
Q4 2017

Feb 14, 2018
BUY
$59.94 - $65.35 $145,414 - $158,539
2,426 Added 55.8%
6,774 $415,000
Q3 2017

Nov 14, 2017
BUY
$55.23 - $63.74 $240,140 - $277,141
4,348
4,348 $277,000

Others Institutions Holding BMY

# of Institutions
2,537
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Apriem Advisors Portfolio

Follow Apriem Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apriem Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Apriem Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email